Onconic Therapeutics Stock Forecast

Buy or Hold candidate since Aug 04, 2026 Gain 17.39%

The Onconic Therapeutics stock price gained 1.23% on the last trading day (Tuesday, 11th Aug 2026), rising from ₩14,670.00 to ₩14,850.00. During the last trading day the stock fluctuated 4.67% from a day low at ₩14,570.00 to a day high of ₩15,250.00. The price has risen in 7 of the last 10 days and is up by 44.03% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 53 thousand more shares were traded than the day before. In total, 555 thousand shares were bought and sold for approximately ₩8.24 billion.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at ₩15,463.90 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -38.89% during the next 3 months and, with a 90% probability hold a price between ₩4,708.66 and ₩9,450.63 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

476060.KQ Signals & Forecast

The Onconic Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₩13,775.71 and ₩12,360.86. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 06, 2026, and so far it has fallen -6.84%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Onconic Therapeutics stock

Onconic Therapeutics finds support from accumulated volume at ₩14,500.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved ₩680.00 between high and low, or 4.67%. For the last week, the stock has had daily average volatility of 10.68%.

Our recommended stop-loss: ₩14,006.52 (-5.68%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (476060.KQ) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Onconic Therapeutics to open at ₩14,890.00, and during the day (based on 14 day Average True Range), to move between ₩14,159.45 and ₩15,540.55, which gives a possible trading interval of +/-₩1,381.09 (+/-9.75%) up or down from last closing price. If Onconic Therapeutics takes out the full calculated possible swing range there will be an estimated 9.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ₩14,500.00 (2.36%) than the resistance at ₩15,940.00 (7.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Onconic Therapeutics stock A Buy?

Onconic Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.314 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - ₩14,890.00 ( 0.269%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk